GRDX
Gridai Technologies Corp.
$2.28+0.03 (1.33%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
AzurRx BioPharma, Inc. (AZRX) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
5 transactions (past 365 days)
| 2026-01-08 | 2026-01-01 | Borkowski Edward | Director | Award | 40,000 | $0.00 | $0 |
| 2026-01-05 | 2026-01-01 | Uppal Manpreet | Director | Award | 40,000 | $0.00 | $0 |
| 2026-01-05 | 2026-01-01 | Pursglove Geordan Garrett | Director | Award | 40,000 | $0.00 | $0 |
| 2025-12-29 | 2025-12-22 | Sawyer Jason David | CEO | Award | 40,000 | $0.00 | $0 |
| 2025-12-29 | 2025-12-22 | Skowron Anna | CFO | Award | 65,000 | $0.00 | $0 |